These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 2670398)

  • 21. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human surfactant in the treatment of respiratory distress syndrome. A spectrum of clinical responses.
    Hallman M; Pohjavuori M; Järvenpää AL; Bry K; Merritt TA; Pesonen E
    Eur Respir J Suppl; 1989 Mar; 3():77S-80S. PubMed ID: 2663000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surfactant to premature neonates].
    Jacobsen T; Verder H
    Ugeskr Laeger; 1991 Jul; 153(31):2166-9. PubMed ID: 1866827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surfactant aerosol treatment of respiratory distress syndrome in the spontaneously breathing premature rabbit.
    Ellyett KM; Broadbent RS; Fawcett ER; Campbell AJ
    Pediatr Res; 1996 Jun; 39(6):953-7. PubMed ID: 8725254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Newer pathophysiologic considerations and treatment of neonatal respiratory distress syndrome (RDS)].
    Fujiwara T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1033-43. PubMed ID: 3075225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surfactant treatment of premature infants with respiratory distress syndrome].
    Saugstad OD; Gloppestad K
    Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The surfactants.
    Kallapur S; Ikegami M
    Am J Perinatol; 2000; 17(7):335-43. PubMed ID: 12141520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The exogenous surfactant and its effect on the respiratory distress syndrome (RDS)].
    Brabec R; Zoban P; Tomásová H
    Cesk Fysiol; 1996 Sep; 45(3):139-45. PubMed ID: 8974827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Old and new uses of surfactant.
    Gizzi C; Papoff P; Barbàra CS; Cangiano G; Midulla F; Moretti C
    J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():41-4. PubMed ID: 20836732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of respiratory distress syndrome: synergistic therapies.
    Gross I
    Mead Johnson Symp Perinat Dev Med; 1988; (33):37-41. PubMed ID: 2485442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of surfactant from 1980.
    Halliday HL
    Biol Neonate; 2005; 87(4):317-22. PubMed ID: 15985754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond.
    Sürmeli-Onay O; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2012; 54(3):239-46. PubMed ID: 23094533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Untapped therapeutic potential of surfactant proteins: is there a case for recombinant SP-D supplementation in neonatal lung disease?
    Clark HW
    Neonatology; 2010 Jun; 97(4):380-7. PubMed ID: 20551708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant replacement therapy in developing countries.
    Vidyasagar D; Velaphi S; Bhat VB
    Neonatology; 2011; 99(4):355-66. PubMed ID: 21701209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.